Behavioral Interventions for Chronic Insomnia
(IBI Trial)
Trial Summary
What is the purpose of this trial?
This randomized pilot study (n=20) explores the effects of a behavioral intervention, that includes sleep hygiene improvements, in long-term users of sleeping pills, aiming to alleviate or stabilize symptoms of insomnia, monitor and decrease sleeping pill usage. Adherence will be monitored by an optional smartphone application.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it aims to monitor and decrease sleeping pill usage. It might be possible that you will be asked to reduce your sleeping pill intake during the study.
What data supports the effectiveness of the treatment Behavioral Interventions for Chronic Insomnia?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is widely recognized as the first-line treatment for chronic insomnia, with strong evidence showing it leads to meaningful and lasting improvements in sleep patterns. Non-drug approaches like CBT-I, which include techniques such as sleep hygiene education, stimulus control, and relaxation training, have been shown to reliably improve sleep in people with insomnia.12345
Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is considered a safe treatment for insomnia, as it does not involve medications and focuses on changing sleep habits and behaviors. It is recommended as a first-line treatment because it produces sustained benefits without the risk of side effects associated with medications.12678
How is the treatment for chronic insomnia using cognitive-behavioral therapy different from other treatments?
Cognitive-behavioral therapy for insomnia (CBT-I) is unique because it focuses on changing sleep habits and beliefs about sleep through structured sessions, rather than using medication. It includes techniques like sleep hygiene education, stimulus control, and relaxation training, and is recognized as the first-line treatment for chronic insomnia due to its effectiveness and long-lasting results.12469
Eligibility Criteria
This trial is for adults aged 55-85 who have been diagnosed with chronic insomnia and regularly use sleeping pills at least three nights a week. Participants must be able to speak English, use a smartphone or tablet, and have internet access. Those with acute medical conditions or severe mental health issues like major depression or psychosis are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a behavioral intervention including sleep hygiene improvements and coaching support
Follow-up
Participants are monitored for changes in sleep pill dosage and sleep efficiency
Treatment Details
Interventions
- Behavioral approach 1
- Behavioral approach 2
Behavioral approach 1 is already approved in United States, European Union, Canada for the following indications:
- Chronic Insomnia Disorder
- Insomnia
- Sleep Disorders
- Insomnia
- Sleep Disturbances
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor